What Spellbinder Corporation does

Spellbinder Corporation (legal entity Spellbinder AI, Inc.) is a private U.S. healthcare-software company founded in 2024 and headquartered in New York. The company sells a physician intelligence SaaS platform to biopharmaceutical companies, serving three distinct internal buyer groups within each customer: clinical trial teams (investigator identification, patient recruitment, site activation), medical affairs teams (KOL identification, peer-network mapping, MSL scientific-exchange prep), and commercial or sales teams (physician targeting, call prep, daily visit planning, territory management).

The product is built on a unified data layer aggregating 1,231,982+ U.S. physician records from 400+ public datasets, including prescription patterns, clinical trial history, PubMed publications, industry payment data, hospital affiliations, peer networks, and patient demographics. On top of this data layer are three core modules: Smart Targeting, which delivers ranked physician lists tailored to the requesting team's use case (patient population match for clinical, peer-network position for medical affairs, conversion potential for commercial); Physician Dossiers, real-time physician profiles; and Conversion Intelligence, which generates personalized pre-meeting briefs including eligibility questions, open scientific questions, efficacy data, and anticipated objections that refine as relationships develop. The platform requires no customer-side IT integration and is positioned as HIPAA- and MLR-compliant.

Spellbinder operates an enterprise SaaS revenue model with subscription fees set in customer-specific Order Forms, invoiced annually, with named Authorized User entitlements and a contractual 5% renewal escalator. Distribution is exclusively direct enterprise sales through a "Book a demo" funnel — there is no self-serve, marketplace, or channel partner motion, and there is no public pricing. Geographic coverage is limited to the United States. The company is private, venture-style (founders described as early Palantir and Squarespace product veterans), with no funding rounds, named investors, leadership team, or revenue figures disclosed in available source material. Customer evidence consists of a single anonymous reference (an unnamed Emerging Pharmaceutical Company), and one company-cited outcome metric of 96% targeting accuracy and 2.3x conversion lift.

Name

Spellbinder Corporation

Legal name

Spellbinder AI, Inc.

Website

https://spellbinder.ai

Company type

Private

Founded year

2024

Operating status

Operating

Headcount range

1–10 employees

Short description

Spellbinder is a New York-based SaaS company, founded in 2024, that sells an AI-powered physician intelligence platform to biopharmaceutical clinical, medical affairs, and commercial sales teams, aggregating 1.2M+ U.S. physician records from 400+ public datasets to deliver ranked physician lists, dossiers, and personalized engagement briefs.

Ownership category

akta.pro rank

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. SaaS Subscription Services: Spellbinder operates as a SaaS subscription platform. Fees are set in Order Forms, invoiced annually, with a 5% renewal increase or as otherwise notified. The subscription is a per-seat or entitlement-based model with named Authorized Users.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Spellbinder provides a physician intelligence SaaS platform for biopharma companies that aggregates 400+ public datasets to deliver ranked physician lists, comprehensive physician dossiers covering prescribing patterns, clinical trial history, publications, peer networks, and hospital affiliations, and AI-generated personalized pre-meeting engagement briefs. The platform serves clinical trial teams, medical affairs teams, and commercial sales teams across the U.S. drug lifecycle, from investigator identification to commercial launch.

Product overview

Spellbinder is a unified physician intelligence SaaS platform for biopharma companies. The core product integrates Smart Targeting (AI-ranked physician lists), Physician Dossiers (comprehensive profiles from 400+ data sources), and Conversion Intelligence (personalized engagement briefs). The platform serves clinical trials, medical affairs, and commercial teams with physician engagement from first trial to commercial launch. Zero setup and no IT integration required — physicians are ranked and briefed automatically, with dossiers refreshed in real-time.

Differentiator

Problem solved

Functional benefit

Products and services

• Spellbinder Unified physician intelligence SaaS platform for U.S. biopharmaceutical companies that integrates more than 400 public datasets into ranked physician lists, comprehensive real-time dossiers, and AI-generated personalized pre-meeting briefs. The platform is used by clinical trial teams for investigator identification and site activation, by medical affairs teams for KOL mapping and scientific exchange preparation, and by commercial sales teams for prioritized call lists and conversion intelligence, with no internal IT integration required to start.

Named customers1 record

Segments3 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature4 records

Scale indicators3 records

Recent moves4 records

Expansion highlights5 records

Broad incumbents

• Veeva Systems: Veeva is the dominant cloud platform for pharma, spanning CRM, data, and commercial operations. It overlaps with Spellbinder's commercial targeting and medical affairs use cases but as part of a much broader, enterprise-wide suite rather than a specialized physician intelligence layer.
• ZoomInfo: ZoomInfo is a broad B2B sales and marketing intelligence platform with healthcare coverage including physician and provider data. It overlaps with Spellbinder on the data-aggregation and target-ranking mechanics, but addresses a much wider set of industries and is not specialized in pharma workflows.
• IQVIA: IQVIA operates the largest global commercial intelligence, RWD, and analytics franchise in life sciences. It competes with Spellbinder across clinical investigator identification, KOL mapping, and commercial targeting, but as a full-service data and services giant rather than a focused SaaS product.

Emerging players

• Sermo: Sermo is a physician community platform that also monetizes physician insights and real-world data sold to pharma. It overlaps with Spellbinder on the data layer (physician signal) but is differentiated by the social/community surface, making it an emerging player with partial category overlap.

Direct peers

• Komodo Health: Komodo Health offers a healthcare intelligence platform built on real-world patient and provider data, with use cases spanning clinical development, medical affairs, and commercial targeting. It is a direct peer in physician/provider intelligence for life sciences, with a similar horizontal GTM into pharma.
• Doximity: Doximity is the leading physician network in the U.S. and has expanded into physician data, newsfeeds, and commercial messaging sold to pharma and med-device companies. It is a direct peer in serving pharma access to U.S. physicians and overlaps with Spellbinder's commercial and KOL engagement workflows.
• Definitive Healthcare: Definitive Healthcare provides healthcare commercial intelligence spanning physicians, hospitals, and IDNs, and is sold into pharma sales, marketing, and medical affairs teams. It is the closest direct competitor in terms of category (physician intelligence for biopharma commercial use) and target buyer.
• Aktana (by Upland): Aktana provides AI-driven commercial intelligence and next-best-action for pharma field teams, including physician targeting, call planning, and engagement optimization. It is a direct peer in AI-augmented pharma commercial targeting and operates at a similar point in the pharma GTM stack.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/spellbinderai

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Spellbinder Corporation